期刊文献+

ABCC2基因单核苷酸多态性对药物临床应用的影响 被引量:2

Effect of Single Nucleotide Polymorphisms in ABCC2 on Clinical Drug Application
下载PDF
导出
摘要 目的:综述ABCC2基因单核苷酸多态性对药物临床应用的影响。方法:通过查阅国内外已发表见刊的相关文献,对ABCC2基因单核苷酸突变与药物临床应用的相关性加以归纳总结。结果:ABCC2转运蛋白在许多内源性化合物和外源性化合物的跨膜转运中起到重要作用。大量研究证明了ABCC2的单核苷酸突变可能影响其表达水平或功能活性,进而影响底物药物或有毒物质的吸收、分布和排泄,但这些研究结果多数存在一定的局限性和争议。结论:ABCC2单核苷酸多态性对某些药物的临床应用有一定的影响,对指导临床用药和评估药物疗效有重要的参考价值,但目前并不能作为唯一的指标。 Objective: To summarize the single nucleotide polymorphisms (SNPs) in ABCC2 and the effect on clinical drug application. Methods: According to the related articles published in domestic and abroad, the correlation between the single nucleotide po1ymorphisms in ABCC2 and drug responses was classified and summarized. Results: ABCC2 translocator played an important role in the transmembrane transport of many physiological compounds and exogenous compounds. Numerous studies have demonstrated that the single nuchotide polymorphisms in ABCC2 possibly affected the expression or activity of ABCC2, which leading to the variation in the absorption, distribution and excretion of certain drugs and toxicants. However, the limitation and controversy were still emerged in the results. Conclusion: The influence of ABCC2 single nucleotide polymorphisms on clinical drug application shows significantly referential value for the guidance of medication and the evaluation of efficacy, however, it can not be used as the only indicator yet.
出处 《中国药师》 CAS 2015年第12期2152-2156,共5页 China Pharmacist
关键词 ABCC2 单核苷酸多态性 跨膜转运 临床影响 ABCC2 Single nucleotide polymorphisms Transmembrane transport Clinical impact
  • 相关文献

参考文献32

  • 1Cascorbi I. Role of pharmacogenetics of ATP-binding cassette trans- porters in the pharmacokinetics of drugs[J]. Pharnu~d Ther,2006, 112(2) :457-473.
  • 2Bruhn O, Cascorbi I. Polymorphisms of the drug transporters ABCBI, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance[ J]. Expert Opin Drug Metab Toxicol2014 ,10 (10) :1337-1354.
  • 3Bos6 V, Herrero MJ, Buso E, et al. Genotype and alle frequencies of drug-metabolizing enzymes and drug transporter genes affecting immu- nosuppressants in the Spanish white population[ J]. Ther Drug Monit, 2014,36(2) :159-168.
  • 4Zghcib NK,Akra-Ismail M, Aridi C,et al. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia[ J]. Pharmaco- genet Genom/cs,2014,24(8) :387-396.
  • 5Kim WJ, Lee JH, Yi J, et al. A nonsynonymous variation in MRP2/ ABCC2 is associated with neurological adverse drug reactions of ear- bamazepine in patients with epilepsy [J].Pharmacogenet Genomics, 2010,20:249-256.
  • 6Radiseh S, Dickens D, Lang TA. Comprehensive functional and clini- cal analysis of ABCC2 and its impact on treatment response to ear- bamazepine [ J ]. Pharrnacogenomic~ J,2014,14 ( 5 ) :481-487.
  • 7Megaraj V, Zhao TY, Paumi CM, et al. Functional Analysis of Non- synonymous Single Nuclcotide Polymorphisms of Muhidrug Resistance Protein 2 (MRP2;ABCC2) [J]. Pharmacogewet C, erwmics, 2011,21(8) : 506-515.
  • 8Jedlitschy G, Hoffmann U, Kroemcr HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition [ J ]. Expert (?pin Drug Metab Toxicol ,2006 ,2 ( 3 ) :351-366.
  • 9Wada M. Single nucleotide polymorphisms in ABCC2 and ABCBI genes and their clinical impact in physiology and drug response [ J ]. Cancer Letters ,2006,234 : 40-50.
  • 10Endo S, Fukahori A, Tokuhiro S, et al. Association study of genetic polymorphisms of drug transporters, SLCO1BI, SLCO1B3 and AB- CC2, in African-Americans, Hispanics and Caucasians and olmesar- tan exposure[ J ]. Journal of Human Genetics ,2012,57:531-544.

二级参考文献12

  • 1陈世清,刘杞,孙航,唐琳,邓建川.二甲双胍对胰岛素抵抗大鼠脂肪肝的影响[J].中华肝脏病杂志,2005,13(12):915-918. 被引量:13
  • 2郭咸希,刘刚,张玲莉,王辉,宋金春.盐酸二甲双胍片的人体药动学研究[J].中国药师,2006,9(10):935-937. 被引量:2
  • 3马小亚,王美纳,梁维薇,王玉虎,董亚琳,王茂义,封卫毅,董卫华.复方盐酸二甲双胍片在健康志愿者体内的药物动力学和生物等效性[J].中国药师,2007,10(10):954-957. 被引量:5
  • 4Fardel O, Jigorel E, Le Vee M, et al. Physiological, pharmacologi- cal and clinical features of the muhidrug resistance protein 2 [ J]. Bi- omed Pharmacother ,2005 ,59 ( 3 ) : 104-114.
  • 5Reed M J, Meszaros K, Entes LJ, et al. A new rat model of type 2 di- abetes : the fat-fed, streptozotocin-treated rat [ J ]. Metabolism,2000, 49( 11 ) :1390-1394.
  • 6Wei M, Ong L, Smith MT, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes [ J ]. Heart Lung Circ ,2003,12 ( 1 ) :44-50.
  • 7Zhou G, Myers R, Li Y,et al. Role of AMP-activated protein kinase in mechanism of metformin action [ J ]. J Clin Invest,2001,108 ( 8 ) : 1167-1174.
  • 8Lee JM, Trauner M, Soroka C J, et al. Expression of the bile salt ex- port pump is maintained after chronic choiestasis in the rat [ J]. Gas- troenterology,2000,118 ( 1 ) : 163-172.
  • 9Courtois A, Payen L, Guillouzo A, et al. Up-regulation of multidi'ug protein 2 (MRP2) expression in rat hepatocytes by dexamethasone [J]. FEBS Lett,1999,459(3) :381-385.
  • 10Lu H, Klaassen C. Gender differences in mRNA expression of ATP- binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats [J]. Drug Metab D/spos,2008, 36(1) :16-23.

共引文献7

同被引文献19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部